Validation of Core Ingredients and Molecular Mechanism of Cinobufotalin Injection Against Liver Cancer
DOI: https://doi.org/10.2147/dddt.s443305
IF: 4.3188
2024-04-23
Drug Design Development and Therapy
Abstract:Shipeng Chen, 1– 3 Mengna Li, 1– 3 Changning Xue, 1– 3 Xiangting Zhou, 1– 3 Jianxia Wei, 1– 3 Lemei Zheng, 1– 3 Yumei Duan, 1– 3 Hongyu Deng, 1 Faqing Tang, 1 Wei Xiong, 1– 3 Bo Xiang, 1– 3 Ming Zhou 1– 3 1 NHC Key Laboratory of Carcinogenesis, Hunan Key Laboratory of Oncotarget Gene, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, People's Republic of China; 2 Cancer Research Institute, Central South University, Changsha, 410078, People's Republic of China; 3 The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Central South University, Changsha, 410078, People's Republic of China Correspondence: Ming Zhou; Bo Xiang, Email ; Purpose: Cinobufotalin injection has obvious curative effects on liver cancer patients with less toxicity and fewer side effects than other therapeutic approaches. However, the core ingredients and mechanism underlying these anti-liver cancer effects have not been fully clarified due to its complex composition. Methods: Multidimensional network analysis was used to screen the core ingredients, key targets and pathways underlying the therapeutic effects of cinobufotalin injection on liver cancer, and in vitro and in vivo experiments were performed to confirm the findings. Results: By construction of ingredient networks and integrated analysis, eight core ingredients and ten key targets were finally identified in cinobufotalin injection, and all of the core ingredients are tightly linked with the key targets, and these key targets are highly associated with the cell cycle-related pathways, supporting that both cinobufotalin injection and its core ingredients exert anti-liver cancer roles by blocking cell cycle-related pathways. Moreover, in vitro and in vivo experiments confirmed that either cinobufotalin injection or one of its core ingredients, cinobufagin, significantly inhibited cell proliferation, colony formation, cell cycle progression and xenograft tumor growth, and the key target molecules involved in the cell cycle pathway such as CDK1, CDK4, CCNB1, CHEK1 and CCNE1, exhibit consistent changes in expression after treatment with cinobufotalin injection or cinobufagin. Interestingly, some key targets CDK1, CDK4, PLK1, CHEK1, TTK were predicted to bind with multiple of core ingredients of cinobufotalin injection, and the affinity between one of the critical ingredients cinobufagin and key target CDK1 was further confirmed by SPR assay. Conclusion: Cinobufotalin injection was confirmed to includes eight core ingredients, and they play therapeutic effects in liver cancer by blocking cell cycle-related pathways, which provides important insights for the mechanism of cinobufotalin injection antagonizing liver cancer and the development of novel small molecule anti-cancer drugs. Keywords: cinobufotalin injection, liver cancer, cinobufagin, network pharmacology, cell cycle, core ingredients Graphical Liver cancer is the fourth leading cause of cancer-related death worldwide, 1 and its morbidity and mortality are increasing, which seriously threatens human life and health. 2 The onset of liver cancer is complex and hidden, and most patients already have advanced liver cancer when they are diagnosed. 3 Chemotherapy is one of the best options for the treatment of liver cancer, 4 but transarterial chemoembolization and chemotherapeutic drugs such as sorafenib cause potent toxic effects, side effects and drug resistance; 5,6 thus, it is necessary to explore complementary and alternative medicines for liver cancer treatment. In recent years, with the increasing modernization of traditional Chinese medicine (TCM), the treatment of cancer with integrated traditional Chinese and western medicines has become a common clinical strategy and research hotspot. 7 Some TCMs used alone or combined with radiotherapy and chemotherapy can improve the sensitivity of chemotherapy, improve the immune system function and reduce the side effects and complications caused by chemotherapy for improving the quality of life for patients. 8 Cinobufotalin injection (CI) is an anti-cancer traditional Chinese medicinal preparation independently researched and developed in China, which contains water-soluble ingredients extracted from the skin of Bufo gargarizans Cantor or Duttaphrynus melanostictus Schneider. 9 A large number of clinical trials showed that cinobufotalin injectio -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal